Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range.
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group.
Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases.
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.
The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.
Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography tandem mass spectrometry.
Clinical Reasoning: An unusual cause of transverse myelitis?
Understanding the pharmacology of stroke and multiple sclerosis through imaging.
Distribution of CD4(pos) -, CD8(pos) - and Regulatory T Cells in the Upper and Lower Gastrointestinal Tract in Healthy Young Subjects.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
Treatment of sleep disorders may improve fatigue in multiple sclerosis.
Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis.
Towards Establishing a Multiple Sclerosis Biobank in Jordan.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Negative work events and accommodations in employed multiple sclerosis patients.
Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents α-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy.
The Role of Geranylgeranyltransferase I-Mediated Protein Prenylation in the Brain.
Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Systemic lupus erythematosus presented as extensive longitudinal myelitis.
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »